Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 220Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 129AMARIN PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8399446

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-02-09

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8431560

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-02-09

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8501225

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-04-29

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8524698

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-02-09

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8546372

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-02-09

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8445013

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-04-29

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8518929

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-02-09

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8399446

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-02-09

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8546372

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-02-09

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ICOSAPENT ETHYL

US Patent Number : 8617594

Drug Substance Claim :

Drug Product Claim :

Application Number : 202057

Patent Use Code : U-1287

Delist Requested :

Patent Use Description : METHOD OF REDUCING TG ...

Patent Expiration Date : 2030-04-29

blank